The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Is The Estimated Growth In Market Size Of The Contract Development Manufacturing Organizations Market During 2026–2030?
The market size for contract development manufacturing organizations has experienced substantial expansion in recent years. This market is projected to expand from $274.79 billion in 2025 to $309.9 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 12.8%. Historical growth in this sector is largely due to factors like cost optimization achieved through outsourcing, increasing research and development investment within the pharmaceutical industry, the expanding production of generic drugs, heightened regulatory complexity, and constraints in internal manufacturing capabilities.
The contract development manufacturing organizations market is projected to experience substantial growth in the upcoming years. It is anticipated to reach a value of $503.82 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.9%. This expansion over the forecast period is attributable to factors such as the rise of biologics and advanced therapies, a growing need for adaptable manufacturing capabilities, the broadening reach of small and medium-sized pharmaceutical enterprises, heightened clinical trial engagement, and an expanding global pharmaceutical pipeline. Key trends anticipated during the forecast period encompass a surge in the outsourcing of drug development and manufacturing processes, an escalating requirement for integrated CDMO services, growth in the production of biologics and biosimilars, an intensified emphasis on adherence to regulations and quality control, and an increase in manufacturing capacity within developing pharmaceutical markets.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3885&type=smp
What Important Drivers Are Powering The Contract Development Manufacturing Organizations Market Growth?
The escalated demand for pharmaceutical items, stemming from a rise in chronic diseases and the aging demographic, has spurred the growth of the contract development manufacturing organizations market. The increase in chronic illnesses and the elderly population has enabled pharmaceutical enterprises to rapidly produce biologics and biosimilars, leading most pharmaceutical companies to contract contract production and manufacturing organizations, which operate on a contractual basis, to manage and coordinate their company’s tasks, operations, and tests. For example, in November 2023, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based, trade association, the overall pharmaceutical production in Europe amounted to €390,000 million ($422,803 million) in 2023, an increase from €363,300 million ($393,857 million) in 2022. Consequently, the rising demand for pharmaceutical products is fueling the expansion of the contract development manufacturing organizations market.
How Does Segment Analysis Break Down The Contract Development Manufacturing Organizations Market Structure?
The contract development manufacturing organizations market covered in this report is segmented –
1) By Service: CMO, CRO
2) By Product: Small Molecules, Biologics
3) By End User: Big Pharma, Small and Mid-size Pharma, Generic Pharmaceutical Companies, Other End Users
Subsegments:
1) By CMO (Contract Manufacturing Organization): API (Active Pharmaceutical Ingredient) Manufacturing, Formulation Development, Finished Product Manufacturing, Packaging Services
2) By CRO (Contract Research Organization): Preclinical Research Services, Clinical Trial Management, Data Management And Biostatistics, Regulatory Affairs Consulting
What Trends Are Impacting The Contract Development Manufacturing Organizations Market?
Key players within the contract development and manufacturing organizations market are prioritizing novel advancements, including Lifera, to boost their earnings within this sector. Lifera functions as a contract development and manufacturing organization (CDMO) capable of commercial-scale operations. An example of this is the launch of Lifera in June 2023 by the Public Investment Fund (PIF), which is Saudi Arabia’s international investment entity. Lifera’s main objective will involve producing essential biopharmaceutical products, including insulin, vaccinations, monoclonal antibodies, plasma treatments, cell and gene therapies, and advanced small chemicals. Furthermore, to enhance local production capabilities and foster domestic manufacturing within this industry, the company intends to forge partnerships with leading national and international enterprises and attract targeted investments. Among Lifera’s aims are to advance formulation development, medication development, and manufacturing processes.
Which Firms Are Competing In The Contract Development Manufacturing Organizations Market?
Major companies operating in the contract development manufacturing organizations market are Recipharm AB, AbbVie Contract Manufacturing LLC, Almac Group Limited, Baxter BioPharma Solutions LLC, Boehringer Ingelheim International GmbH, Catalent Pharma Solutions Inc., CMIC Holdings Co. Ltd., Covance Inc., Evotec SE, Famar Health Care Services Madrid SA, Jubilant Life Sciences Limited, Lonza Group Ltd., Patheon UK Limited, Pfizer CentreOne, Thermo Fisher Scientific Inc., Vetter Pharma International GmbH, Advanced BioScience Laboratories Inc., Adare Pharmaceuticals Inc., Aenova Holding GmbH, Ajinomoto Bio-Pharma Services, Albany Molecular Research Inc., Cambrex Corporation, CordenPharma International GmbH, EirGen Pharma Limited, Grand River Aseptic Manufacturing, Hovione LLC, Metrics Contract Services, NextPharma Technologies Holding Limited, Nitto Avecia Pharma Services Inc., Piramal Pharma Solutions Inc., Siegfried Holding AG, Therapure Biopharma Inc., Velesco Pharmaceutical Services, WuXi PharmaTech (Cayman) Inc.
Access The Complete Contract Development Manufacturing Organizations Market Report:
Which Region Stands As The Largest Contributor To The Contract Development Manufacturing Organizations Market?
North America was the largest region in contract development manufacturing organizations market in 2025. The regions covered in the contract development manufacturing organizations market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Contract Development Manufacturing Organizations Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=3885&type=smp
Browse Through More Reports Similar to the Global Contract Development Manufacturing Organizations Market 2026, By The Business Research Company
Contract Development Manufacturing Organizations Market Report 2026
Contract Research And Manufacturing Services Market Report 2026
Electronic Contract Manufacturing And Design Services Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model